This study, which complied with all relevant ethical regulations for work with human participants was conducted on a total of 367 paraffin-embedded ovarian cancer samples and four freshly collected ovarian cancer tissues that were histopathologically and clinically diagnosed at the Affiliated Guangzhou Women and Children's Hospital and Sun Yat-sen University Cancer Center. The clinical information regarding the samples is summarized in Supplementary Tables S3 and S4. All patients received standardized platinum-based chemotherapy. Platinum resistance and sensitivity refer to the time-to-relapse within 6 months or after 6 months following completion of platinum-based chemotherapy. The study protocols were approved by the Institutional Research Ethics Committee of Sun Yat-sen University Laboratory Animal Center for the use of these clinical materials for research purposes.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.